Olaf Kinzel

1.9k total citations
42 papers, 964 citations indexed

About

Olaf Kinzel is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Olaf Kinzel has authored 42 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Olaf Kinzel's work include Drug Transport and Resistance Mechanisms (10 papers), HIV/AIDS drug development and treatment (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Olaf Kinzel is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), HIV/AIDS drug development and treatment (6 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Olaf Kinzel collaborates with scholars based in Italy, United States and Germany. Olaf Kinzel's co-authors include Claus Kremoser, Andreas Schulz, Michael Rowley, Christian Gege, Eva Hambruch, H. Budzikiewicz, Ulrich Deuschle, Thomas Schlüter, Christoph Steeneck and Giovanna Pescatore and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Olaf Kinzel

42 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olaf Kinzel Italy	17	389	345	255	203	126	42	964
Daniel Vitt Germany	20	435 1.1×	137 0.4×	168 0.7×	205 1.0×	52 0.4×	45	906
James M. Fujitaki United States	18	585 1.5×	87 0.3×	132 0.5×	267 1.3×	88 0.7×	34	1.2k
Johan Vande Voorde Belgium	16	872 2.2×	220 0.6×	98 0.4×	181 0.9×	61 0.5×	25	1.3k
Serge H. Boyer United States	18	473 1.2×	72 0.2×	424 1.7×	245 1.2×	87 0.7×	28	1.2k
John T.-A. Hsu Taiwan	17	494 1.3×	139 0.4×	78 0.3×	152 0.7×	27 0.2×	32	1.1k
Michel Garneau Canada	21	495 1.3×	113 0.3×	212 0.8×	339 1.7×	15 0.1×	57	1.3k
Charles E. Mazzucco United States	18	402 1.0×	151 0.4×	128 0.5×	649 3.2×	71 0.6×	26	1.4k
Ingrid Choong United States	12	646 1.7×	156 0.5×	318 1.2×	160 0.8×	16 0.1×	20	1.5k
Shunji Izuta Japan	15	476 1.2×	149 0.4×	97 0.4×	89 0.4×	38 0.3×	29	726
Yong-Lian Zhu United States	14	513 1.3×	159 0.5×	75 0.3×	109 0.5×	18 0.1×	22	804

Countries citing papers authored by Olaf Kinzel

Since Specialization

Citations

This map shows the geographic impact of Olaf Kinzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Kinzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Kinzel more than expected).

Fields of papers citing papers by Olaf Kinzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Kinzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Kinzel. The network helps show where Olaf Kinzel may publish in the future.

Co-authorship network of co-authors of Olaf Kinzel

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Kinzel. A scholar is included among the top collaborators of Olaf Kinzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Kinzel. Olaf Kinzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hollenback, David, Eva Hambruch, Andreas Schulz, et al.. (2024). Development of Cilofexor, an Intestinally-Biased Farnesoid X Receptor Agonist, for the Treatment of Fatty Liver Disease. Journal of Pharmacology and Experimental Therapeutics. 389(1). 61–75. 3 indexed citations

Steeneck, Christoph, Olaf Kinzel, Simon Anderhub, et al.. (2020). Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. ACS Medicinal Chemistry Letters. 11(2). 179–187. 15 indexed citations

Kinzel, Olaf, Christoph Steeneck, Simon Anderhub, et al.. (2020). Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold. Bioorganic & Medicinal Chemistry Letters. 33. 127738–127738. 4 indexed citations

Steeneck, Christoph, Christian Gege, Olaf Kinzel, et al.. (2020). Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach. Bioorganic & Medicinal Chemistry Letters. 30(12). 127174–127174. 14 indexed citations

Gege, Christian, M. Albers, Olaf Kinzel, et al.. (2020). Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt. Bioorganic & Medicinal Chemistry Letters. 30(12). 127205–127205. 10 indexed citations

Steeneck, Christoph, Olaf Kinzel, Simon Anderhub, et al.. (2020). Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 33. 127744–127744. 12 indexed citations

Kinzel, Olaf, Christoph Steeneck, Thomas Schlüter, et al.. (2016). Novel substituted isoxazole FXR agonists with cyclopropyl, hydroxycyclobutyl and hydroxyazetidinyl linkers: Understanding and improving key determinants of pharmacological properties. Bioorganic & Medicinal Chemistry Letters. 26(15). 3746–3753. 27 indexed citations

Gege, Christian, Olaf Kinzel, Christoph Steeneck, Andreas Schulz, & Claus Kremoser. (2014). Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities. Current Topics in Medicinal Chemistry. 14(19). 2143–2158. 52 indexed citations

Deuschle, Ulrich, Julia Schüler, Andreas Schulz, et al.. (2012). FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model. PLoS ONE. 7(10). e43044–e43044. 72 indexed citations

10.

Abel, Ulrich, Thomas Schlüter, Andreas Schulz, et al.. (2010). Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists. Bioorganic & Medicinal Chemistry Letters. 20(16). 4911–4917. 47 indexed citations

11.

Ferrigno, Federica, Danila Branca, Olaf Kinzel, et al.. (2009). Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorganic & Medicinal Chemistry Letters. 20(3). 1100–1105. 14 indexed citations

12.

Pescatore, Giovanna, Danila Branca, Olaf Kinzel, et al.. (2009). Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters. 20(3). 1094–1099. 17 indexed citations

13.

Branca, Danila, Federica Ferrigno, Olaf Kinzel, et al.. (2009). Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway. Bioorganic & Medicinal Chemistry Letters. 19(15). 4191–4195. 17 indexed citations

14.

Fonsi, Massimiliano, Philip Jones, Olaf Kinzel, et al.. (2009). Metabolism-related liabilities of a potent histone deacetylase (HDAC) inhibitor and relevance of the route of administration on its metabolic fate. Xenobiotica. 39(10). 722–737. 5 indexed citations

15.

Donghi, Monica, Olaf Kinzel, & Vincenzo Summa. (2009). 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—A new class of HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(7). 1930–1934. 24 indexed citations

16.

Pescatore, Giovanna, Olaf Kinzel, Massimiliano Fonsi, et al.. (2008). Optimization of a series of potent and selective ketone histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5528–5532. 11 indexed citations

17.

Gallinari, Paola, Armin Lahm, Uwe Koch, et al.. (2005). A Functionally Orthogonal Estrogen Receptor-Based Transcription Switch Specifically Induced by a Nonsteroid Synthetic Ligand. Chemistry & Biology. 12(8). 883–893. 14 indexed citations

18.

Fattori, Daniela, Olaf Kinzel, Paolo Ingallinella, Elisabetta Bianchi, & Antonello Pessi. (2002). A practical approach to the synthesis of hairpin polyamide–peptide conjugates through the use of a safety-catch linker. Bioorganic & Medicinal Chemistry Letters. 12(8). 1143–1147. 7 indexed citations

19.

Kinzel, Olaf & H. Budzikiewicz. (1999). Synthesis and biological evaluation of a pyoverdin‐β‐lactam conjugate: a new type of arginine‐specific cross‐linking in aqueous solution. Journal of Peptide Research. 53(6). 618–625. 31 indexed citations

20.

Kinzel, Olaf, Robert Tappe, Igor I. Gerus, & H. Budzikiewicz. (1998). The Synthesis and Antibacterial Activity of two Pyoverdin-ampicillin Conjugates, Entering Pseudomonas aeruginosa via the Pyoverdin-mediated Iron Uptake Pathway.. The Journal of Antibiotics. 51(5). 499–507. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact